Dan Carroll

Diagnostics have been taking off around health care, from fast risers like Illumina to tried-and-true companies like Thermo-Fisher. Don't miss out on this health boom.

Two of the Dow's biggest big pharma companies will report earnings next week, but will Merck and Pfizer fight off the patent cliff in the wake of falling sales recently?

Japanese stocks like electronics leader Sony have soared in 2013, but Japan's lagging exports are threatening the Nikkei's gains.

Boeing and Wal-Mart hope to take advantage of rising trends in the world's second-largest economy

Chemicals giants BASF and Bayer look like strong picks for the future, but is Germany's economic base solid enough to keep the DAX's recent surge alive?

UnitedHealth will need to keep growing its subscription base in order to beat any rising costs stemming from health care reform's rollout.

AstraZeneca has been hit hard by the patent cliff and has severely underperformed some of its big pharma peers in 2013. Can new drugs help offset AstraZeneca's future losses?

Boston Scientific's stock has roared higher in 2013, but are dangers awaiting investors ahead?

Bristol-Myers Squibb and GlaxoSmithKline both revealed their third quarter earnings recently, and what each company released shows a lot about where these firms are headed

Johnson & Johnson's medical device division's lackluster third quarter leaves investors wondering whether this key business will turn things around

Merck and Pfizer hold off losses despite a downbeat day from the Dow Jones.

The Dow Jones has retreated from triple-digit gains as Pfizer and Johnson & Johnson help keep the index in the green.

The Dow Jones gets off to a slow start as Johnson & Johnson and UnitedHealth can't stay out of the red after last week's wildly different earnings reports.

With Obamacare's federal exchange site beset with glitches and vulnerable to hackers and scammers, will stocks relying on the new law such as eHealth, CGI, and big insurers like WellPoint suffer the effects of this law's flawed launch?

Merck, Sanofi, and Novo Nordisk hold court among suitors to diabetes' growing global market.

Yingli Green Energy and Trina Solar are two of China's growth companies looking for a steady economic foundation at home to build upon.

Germany's investments have grown after a lackluster start to the year, but BASF and Siemens are looking to the long run for gains

The country's largest publicly-traded insurer can't find any momentum after earnings disappointed Wall Street yesterday

Nutrition leaders Nestle and Danone have struggled with China's probe and guidance questions, but Abbott Labs continues to shine.

Boston Scientific and Medtronic have dealt with lagging CRM sales recently, but St. Jude Medical's surprising defibrillator results show promise for the future of this industry.